Cosmos Health Inc.

Contributing Author

Recent Articles by Cosmos Health Inc.

Sep-11	Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units COSM GlobeNewswire
Aug-18	Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 COSM GlobeNewswire
Aug-12	Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy COSM GlobeNewswire
Aug-06	Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy COSM GlobeNewswire
Jun-24	Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech COSM GlobeNewswire
May-15	RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven COSM GlobeNewswire
May-15	Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven COSM GlobeNewswire
May-07	Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units COSM GlobeNewswire
May-06	Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq COSM GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.